Clinical Trial Update: Hypertrophic Regression With N-Acetylcysteine in HCM [Phase 1]

View source ↗

Summary

Phase 1 trial update investigating N-Acetylcysteine for hypertrophic regression in hypertrophic cardiomyopathy; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Hypertrophic Cardiomyopathy | Phase 1 | Status: COMPLETED | Results posted: 2021-11-02